PMHNP Scope of Practice for Depression in Michigan

If you’re a psychiatrist or PMHNP wondering whether you can treat depression patients via telehealth and prescribe medications remotely, the short answer is: yes — with some important caveats that vary by state and provider type.

The regulatory landscape for telehealth prescribing has evolved dramatically since COVID-19, and while the rules are generally provider-friendly in 2025-2026, there are key differences between what psychiatrists can do versus PMHNPs, and what’s allowed in California versus Texas versus Florida.

Let me walk you through what you actually need to know to practice legally and build a sustainable telehealth depression practice.

The Federal Picture: DEA Rules Through 2026

Here’s the critical federal context: most depression medications aren’t controlled substances, so they’re not subject to DEA telehealth restrictions at all. SSRIs, SNRIs, bupropion, mirtazapine — you can prescribe these via telehealth under the same standard of care as in-person. No special federal rules apply.

The complexity comes when you’re treating co-occurring conditions that require controlled substances — anxiety with benzodiazepines, ADHD with stimulants, insomnia with certain sleep aids, or treatment-resistant depression augmented with controlled medications.

The current federal rules (extended through December 31, 2026): You can prescribe controlled substances via telehealth without an initial in-person visit. This is a temporary extension of COVID-era flexibilities that DEA and HHS have now extended four times, most recently in January 2026. That means a new patient can present with depression and anxiety, and you can initiate both an SSRI and a benzodiazepine via video visit — legally, at the federal level.

What’s coming: DEA proposed new permanent rules in January 2025 that would create a Special Registration for Telemedicine. Under the proposal:

• Providers prescribing Schedule III-V controlled substances via telehealth would need to obtain a special telemedicine registration
• For Schedule II drugs (stimulants like Adderall, certain pain meds), only specific specialists could prescribe via telehealth without an in-person exam — and psychiatrists are explicitly included in that list
• This means psychiatrists would have a clear pathway to tele-prescribe stimulants for ADHD or treatment-resistant depression, while other specialties might face restrictions

These rules aren’t finalized yet, and DEA is taking public comment. But the direction is clear: permanent telehealth prescribing authority is coming for psychiatric practice, with some registration requirements and safeguards.

What you should do now: Operate under the current extension through 2026, document appropriately, and stay alert to DEA announcements. When the special registration system launches (likely late 2026 or 2027), you’ll need to apply — but the barriers appear designed to be manageable for legitimate psychiatric practice.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrist vs PMHNP: Scope of Practice Reality

This is where state law creates the biggest divide in what you can actually do.

Psychiatrists (MD/DO)

Your scope is straightforward: you can diagnose and treat depression, prescribe any medication (controlled or not), and practice independently in all 50 states. The only requirements are:

• A valid medical license in the state where the patient is located
• A DEA registration for controlled substances in that state
• Following standard of care (which is the same via telehealth as in-person)

No collaboration required, no supervision needed, no scope restrictions beyond general medical regulations. If a patient needs esketamine (Spravato), you can prescribe it — though administration must happen in a REMS-certified clinic. If they need a stimulant for treatment-resistant depression, you prescribe it. If the case is complex with psychosis, you manage it or refer as appropriate.

The business reality: This autonomy means you can join a telehealth platform like Klarity, see patients across multiple states (assuming you get licensed in each), and build a practice without administrative friction from collaboration requirements.

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Your scope depends entirely on which state your patient is in. This is the single most important regulatory factor for NP practice.

Full Practice Authority States (California, New York, Illinois — with qualifications):

In these states, experienced PMHNPs can practice independently — diagnose depression, prescribe all medications including controlled substances, no physician oversight required.

• California: If you qualify under AB 890 (3+ years experience, national certification), you can obtain ‘104 NP’ status and practice fully independently as of January 2024. This is new — California was historically restrictive, but AB 890 changed the game for experienced NPs.

• New York: After 3,600 hours of practice (roughly 1.5-2 years full-time), you can practice without a written collaborative agreement or physician supervision. This became permanent in 2022.

• Illinois: You can apply for Full Practice Authority after 4,000 hours of collaborative practice plus additional continuing education. With FPA, you have independent prescriptive authority including Schedule II controlled substances (with some consultation requirements for long-term high-dose opioids).

Restricted Practice States (Texas, Florida, Pennsylvania):

In these states, PMHNPs must have physician collaboration or supervision to prescribe.

• Texas: You need a written Prescriptive Authority Agreement with a physician. The physician must be available for consultation and you must meet regularly (at least monthly) to discuss cases. Schedule II prescribing is extremely limited for NPs in Texas (basically restricted to hospital/hospice settings for outpatient).

• Florida: Psychiatric NPs were explicitly excluded from Florida’s 2020 autonomous practice law (which only covered primary care NPs). You must practice under a protocol with a supervising physician. The good news: psychiatrists can tele-prescribe Schedule II drugs in Florida specifically for psychiatric disorders, so if you’re collaborating with a psychiatrist, the patient can still get appropriate care.

• Pennsylvania: You need a collaborative agreement with a physician to practice and prescribe. The physician doesn’t co-sign prescriptions but must be part of a documented collaboration. PA has been trying to pass NP independence legislation for years — it hasn’t happened yet.

The business reality for PMHNPs: In full-practice states, you can operate similarly to a psychiatrist — join platforms, see patients, prescribe independently. In restricted states, you need a collaborating physician on paper (and sometimes in practice), which affects how you structure your relationship with telehealth platforms. Some platforms will help arrange collaboration; others require you to bring your own.

The scope differences aren’t about clinical competence — they’re about state regulatory structures. But they absolutely affect how you can practice.

State-Specific Telehealth Prescribing Rules

Beyond scope of practice, individual states have telehealth-specific rules that affect prescribing. Let me highlight the most important ones for psychiatric practice:

California

• No state in-person exam requirement for telehealth prescribing
• Telehealth held to same standard as in-person
• Must be licensed in California (no out-of-state telehealth license option; CA isn’t in interstate compacts)
• Strong telehealth parity laws — insurers must cover tele-mental health equivalently
• Check CURES (prescription monitoring database) before prescribing controlled substances
• Recent change: AB 890 now allows experienced NPs to practice independently (as of 2023-2024), which is a major shift for PMHNPs

Texas

• Relationship must be established via audio-visual telemedicine for new patients (phone-only generally insufficient)
• Chronic pain treatment with controlled substances via telehealth is prohibited except under very specific conditions (must have seen patient in-person or video within 90 days, etc.). This doesn’t typically affect depression treatment unless the patient has co-occurring chronic pain managed with opioids.
• No state ban on prescribing psychiatric medications (antidepressants, stimulants for ADHD, benzodiazepines) via telehealth
• Must have full Texas license (Texas is in IMLC for physicians, making multi-state licensing easier)
• NPs must have Prescriptive Authority Agreement with physician — this is non-negotiable in Texas

Florida

• Schedule II controlled substances cannot be prescribed via telehealth EXCEPT for: psychiatric disorders, inpatient hospital care, hospice, or nursing home patients
• This exception is huge for psychiatric practice: you can tele-prescribe Adderall, Ritalin, other stimulants for ADHD or depression augmentation because they fall under ‘treatment of psychiatric disorder’
• Schedule III-V can be tele-prescribed without restriction
• Florida offers out-of-state telehealth registration for providers licensed elsewhere (must renew every 2 years) — this is relatively unique and makes Florida accessible
• PMHNPs cannot practice independently — psychiatric NPs were excluded from autonomous practice law
• Must check E-FORCSE (Florida’s prescription monitoring program) before prescribing controlled substances

New York

• No state in-person exam requirement
• Strong telehealth parity; audio-only allowed for mental health services (especially valuable for patients without reliable video access)
• Electronic prescribing mandatory for controlled substances
• Must be licensed in New York (NY not in IMLC; requires full license)
• Experienced NPs (>3,600 hours) can practice independently as of 2022 — this is now permanent
• Standard of care is the guiding principle; document thoroughly

Pennsylvania

• No formal comprehensive telehealth statute (legislation has stalled), but state guidance confirms telemedicine is permissible within scope of practice as long as standard of care is met
• Must have Pennsylvania license (PA is in IMLC for physicians as of 2021)
• NPs require collaborative agreement — no full practice authority yet despite legislative efforts
• Electronic prescribing required for controlled substances
• Must check prescription monitoring database
• The lack of a clear telehealth law means: obtain explicit patient consent, document standard-of-care equivalent to in-person, have emergency protocols in place

Illinois

• Full Practice Authority available for experienced APRNs after 4,000 hours + additional education
• Strong telehealth law (Public Act 102-0104, enacted 2021) requires insurance parity and protects right to use telehealth
• No state in-person exam requirement
• Telehealth from any location allowed; insurers cannot demand prior in-person visit
• FPA APRNs can prescribe Schedule II-V after obtaining controlled substance license and DEA registration
• Must use Illinois Prescription Monitoring Program
• Consultation requirement for FPA APRNs prescribing long-term Schedule II opioids (doesn’t typically affect depression practice)

The Economics Reality: Why This Matters for Your Practice

Let’s talk business for a moment. Understanding these regulations isn’t just about compliance — it’s about whether you can actually build a sustainable telehealth practice.

The traditional marketing path: If you go solo and try to build your own patient base, you’re looking at:

• SEO: 6-12 months of consistent investment ($2,000-4,000/month for content, technical optimization, link building) before you see meaningful traffic. Most solo providers don’t have the expertise or patience.

• Google Ads: Mental health keywords cost $15-40+ per click. Most clicks don’t convert. Realistic cost per booked patient: $200-400+. And that’s after months of testing and optimization.

• Directory listings: Psychology Today, Zocdoc, etc. charge monthly fees ($30-100+) AND you compete with hundreds of providers on the same page. Zocdoc charges per booking ($35-100+), and when you add subscription costs, total monthly investment adds up quickly with uncertain ROI.

When you factor in agency/consultant fees, ad spend testing, staff time to handle leads, no-show rates from cold leads, and failed campaigns, the true cost to acquire a qualified psychiatric patient through DIY marketing is typically $200-500+.

And that assumes you eventually figure it out. Many providers spend $3,000-5,000/month on marketing for 6-12 months with marginal results.

The platform alternative: This is where understanding regulations connects to business strategy.

Platforms like Klarity Health use a pay-per-appointment model similar to Zocdoc, but with key differences:

• No upfront marketing spend — you don’t pay agency fees, ad costs, or monthly subscriptions while waiting for patients
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert — you only pay when a qualified patient books
• Built-in telehealth infrastructure — no separate platform costs, EHR integration included
• Both insurance and cash-pay patient flow — diversified revenue streams
• You control your schedule — only pay when you actually see patients

The standard listing fee per new patient lead is transparent and predictable. Instead of gambling $3,000-5,000/month on marketing channels with uncertain outcomes, you pay only when a qualified patient shows up on your schedule. That’s guaranteed ROI versus marketing risk.

Why regulations matter here: The reason I spent so much time on state-by-state rules is because your ability to join multi-state platforms and scale revenue depends on understanding these requirements.

If you’re a psychiatrist, you can get licensed in 5-10 states (using IMLC where available) and immediately access patient flow across those markets. If you’re a PMHNP in a full-practice state, same opportunity. But if you’re a PMHNP in Texas or Florida, you need collaboration agreements in place — which platforms can often help arrange, but you need to know that going in.

The states I covered (CA, TX, FL, NY, PA, IL) represent the largest patient populations and biggest opportunities for telepsychiatry revenue. Understanding their specific rules lets you make strategic decisions: ‘Do I prioritize getting licensed in Florida because the telehealth registration is easier?’ or ‘Should I get my Illinois FPA first so I can practice independently across platforms?’

Practical Compliance Checklist

Here’s what you actually need to do to prescribe for depression via telehealth legally:

Every provider, every state:

✓ Valid license in the state where patient is located at time of consultation
✓ DEA registration in that state (for controlled substances)
✓ Verify patient identity and location at start of encounter
✓ Obtain informed consent for telehealth services
✓ Document visit to same standard as in-person (assessment, diagnosis, treatment plan, follow-up)
✓ Use secure, HIPAA-compliant video platform
✓ Check state prescription drug monitoring program before prescribing controlled substances
✓ Use electronic prescribing (required in most states for controlled substances, many states for all prescriptions)
✓ Have emergency protocols in place (how to activate local emergency services if patient is in crisis)

Additional for PMHNPs:

✓ Verify your state’s scope of practice requirements (independent vs collaborative)
✓ If collaboration required, ensure written agreement is current and filed with state board
✓ If state has transition-to-practice requirements for independence (like CA’s AB 890 or NY’s 3,600 hours), document completion
✓ Verify your prescriptive authority for controlled substances in that state (Schedule II limits vary)

Additional for Schedule II prescribing:

✓ Verify current DEA rules (extensions through 2026; monitor for permanent rule changes)
✓ In Florida: ensure diagnosis justifies Schedule II as psychiatric treatment (document in chart)
✓ In Texas: avoid initiating chronic pain treatment with controlled substances via telehealth; use video (not phone) for new controlled substance prescriptions
✓ Document medical necessity and consider non-controlled alternatives where appropriate

Multi-state practice:

✓ Track which states you’re licensed in (maintain list with license numbers, expiration dates)
✓ Use Interstate Medical Licensure Compact if available (psychiatrists) to streamline licensing
✓ Understand each state’s specific telehealth rules (don’t assume they’re all the same)
✓ Consider liability insurance that covers telehealth across your practice states

FAQ: What Providers Actually Ask

Can I prescribe Lexapro to a new patient I’ve never met in person via telehealth?

Yes. Lexapro (escitalopram) is not a controlled substance. Federal law doesn’t restrict it, and no state requires an in-person visit to prescribe non-controlled psychiatric medications via telehealth. Standard of care applies: you need an adequate evaluation (via video), proper diagnosis, informed consent, and documentation. This is true in all 50 states.

Can I prescribe Xanax (alprazolam) via telehealth for a patient with depression and anxiety?

Yes, under current federal rules (through December 31, 2026). Xanax is Schedule IV. The DEA extension allows you to prescribe it via telehealth without a prior in-person visit. State law matters: in Florida, no issue. In Texas, use video (not just phone) for the initial encounter. Document the clinical justification (anxiety disorder, appropriate treatment, considered alternatives, etc.). When DEA finalizes permanent rules, you may need the special telemedicine registration, but for now you’re operating under the extension.

Can I prescribe Adderall via telehealth?

Depends on your specialty and the state. Adderall is Schedule II.

• Psychiatrists: Yes, under current federal extension through 2026. In Florida, specifically yes because it’s for psychiatric treatment. In Texas, yes for ADHD or psychiatric use (just use video encounter). When permanent DEA rules come, psychiatrists will likely be able to obtain the ‘Advanced Telemedicine Prescribing’ registration for Schedule II.

• PMHNPs: Depends on state. In Illinois with Full Practice Authority, yes. In New York with independence, likely yes (follow DEA rules). In Texas, very limited — Schedule II prescribing by NPs is restricted to specific settings (hospital, hospice), so probably not for routine outpatient ADHD via telehealth. In Florida, if you have a supervising psychiatrist who can prescribe it under the psychiatric exception, the patient can get it, but you as an NP might not be the one writing it.

What if my patient moves from New York to Texas mid-treatment?

You need a Texas license to continue treating them via telehealth once they’re physically in Texas. If you don’t have one, you need to transfer care or obtain Texas licensure. Texas doesn’t allow out-of-state telehealth without a license. If you’re a PMHNP, you’d also need a collaborative agreement with a Texas physician to prescribe in TX. This is one reason multi-state licensing is strategically important.

Do I need separate malpractice insurance for telehealth?

Check your current policy. Many malpractice policies now cover telehealth as standard practice. If yours doesn’t, or if it excludes certain states, you’ll need to update it. Make sure your coverage extends to all states where you’re licensed and practicing.

Can I use phone-only (audio-only) for telehealth if the patient doesn’t have video access?

Depends on the state and the clinical situation. New York explicitly allows audio-only for mental health services. Illinois allows it in certain circumstances (especially behavioral health). Texas generally requires video for new patient encounters where prescribing is involved. California allowed it during COVID for mental health; check current guidance. Florida’s statute emphasizes ‘real-time audio and visual’ but emergency exceptions may exist.

Clinically: Audio-only is less ideal (you can’t see patient affect, non-verbal cues, etc.), but for established patients or follow-ups where you know them, it may be acceptable. For initial evaluations where you’re prescribing, most states and standard of care expect video. Document why audio-only was used if it’s the case.

How do I handle prescribing across state lines when insurance requires in-network providers?

This is more of a business/insurance question than regulatory, but it’s common. You need to be credentialed with insurers in each state you practice in if you want to bill insurance. Some platforms handle this (they credential you in multiple states as part of onboarding). If you’re solo, credentialing in 5-10 states with multiple payers is extremely time-consuming — one reason platforms are attractive.

What happens when the DEA telehealth extension expires at the end of 2026?

DEA has committed to finalizing permanent rules before then. The January 2025 proposal suggests they’ll create a registration pathway that allows psychiatric telehealth prescribing to continue. Worst case: if no permanent rule is in place and no further extension, the Ryan Haight Act’s in-person requirement would technically reinstate, meaning you’d need to see new patients in-person once before prescribing controlled substances via telehealth.

Realistically: DEA and HHS know this would disrupt care for hundreds of thousands of patients. They’ve extended four times already. They will almost certainly have a permanent rule in place, or issue another extension. Monitor DEA announcements starting in Q3 2026.

The Bottom Line: Regulatory Clarity Enables Growth

Here’s what you need to remember:

For prescribing non-controlled depression medications (SSRIs, SNRIs, etc.) via telehealth: You’re good to go in all states as long as you’re licensed where the patient is located, follow standard of care, and document appropriately.

For prescribing controlled substances (benzodiazepines, stimulants, certain sleep aids): Current federal rules through 2026 allow it without in-person exams. State-specific rules matter (especially Florida’s psychiatric exception, Texas’s video requirement, etc.). Permanent rules coming likely preserve psychiatric telehealth prescribing with some registration requirements.

For scope of practice: Psychiatrists practice independently everywhere. PMHNPs have full independence in some states (CA, NY, IL with qualifications) and require physician collaboration in others (TX, FL, PA). Know your state’s rules.

For building a sustainable practice: DIY marketing costs $200-500+ per acquired patient and takes 6-12 months to generate consistent flow. Platforms that pre-qualify patients and charge per-appointment remove that risk entirely — you pay only when you see patients, with guaranteed ROI instead of marketing gambles.

The regulatory environment for telepsychiatry is the most favorable it’s been in modern history. States are expanding NP practice authority. DEA is codifying permanent telehealth prescribing rules for psychiatric specialists. Insurance parity laws are making reimbursement equivalent to in-person.

If you understand the regulations in your target states and structure your practice accordingly — whether solo or through a platform — you can build a thriving telehealth depression practice that serves patients who desperately need access while generating sustainable income without the overhead of traditional brick-and-mortar practice.

Ready to explore telehealth practice without the marketing headache? Klarity Health connects psychiatrists and PMHNPs with pre-qualified patients seeking depression treatment. You control your schedule, we handle patient acquisition, and you only pay when you see patients. Learn more about joining our provider network and expanding your practice across multiple states with built-in compliance support.

Sources

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026). Official U.S. Government announcement. www.hhs.gov

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Telemedicine While Also Establishing New Patient Protections’ (January 16, 2025). Official DEA communication on proposed permanent rules. www.dea.gov

3. Florida Statutes §456.47 – ‘Use of Telehealth to Provide Services’ (2019, updated through 2025). Official state law governing telehealth practice and controlled substance prescribing exceptions in Florida. www.leg.state.fl.us

4. Texas Administrative Code Title 22, Part 9 §174.5 – ‘Telemedicine Issuance of Prescriptions’ (Last updated January 15, 2025). Official Texas Medical Board regulation detailing telemedicine prescribing requirements and chronic pain restrictions. txrules.elaws.us

5. California AB 890 Implementation – CA Board of Registered Nursing guidance on nurse practitioner scope expansion (Updated January 2023). Official state board information on NP independent practice authority. www.rn.ca.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service